Addressing Key Questions: Expert Insights to Guide Pathologist-Informed Clinical Decisions in HER2-Expressing or Amplified Solid Tumors

Download slides, watch an on-demand webcast, and review a short commentary from a live symposium at USCAP 2024 in which a panel of pathologists and medical oncologists discussed the nuances of HER2 testing across solid tumors and the impact of testing results on treatment selection.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Jazz Pharmaceuticals, and Seagen.

AstraZeneca

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals

Seagen